Navigation Links
Despite missing primary efficacy endpoint, ATOMIC-AHF identifies positive trends
Date:9/2/2013

AMSTERDAM, The Netherlands Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.

However, a cohort which received the highest dose of the drug showed greater dyspnoea relief compared with placebo, and there were also other favourable dose and concentration-related trends, noted lead investigator John R. Teerlink, MD, Professor of Clinical Medicine at the University of California San Francisco and Director of Heart Failure at the San Francisco Veterans Affairs Medical Center, USA.

"The study was a real success for its purpose, as a dose-finding, safety and tolerability study," he said. "The main objective of ATOMIC-AHF was to investigate the pharmacokinetics and tolerability of intravenous omecamtiv mecarbil in the acute heart failure (AHF) population, and like most Phase II studies, it was not powered or designed around the efficacy endpoint," he explained.

"We are pleased to see as much efficacy signal as was apparent, and the study provides essential data to inform the dosing regimen for future Phase 3 trials of the intravenous formulation."

ATOMIC-AHF enrolled 613 patients with left ventricular systolic dysfunction who were acutely hospitalised with dyspnoea at rest or minimal exertion.

The subjects, from 106 sites in North America, Europe and Australia, were randomly assigned to receive 48 hours of intravenous placebo or omecamtiv mecarbil (OM) in 3 ascending dose cohorts designed to achieve plasma concentrations of 115, 230, and 310 ng/mL.

The primary efficacy endpoint was the effect on dyspnoea at 6, 24 and 48 hours, with secondary endpoints of safety, tolerability, pharmacokinetics, and echocardiographic indices of cardiac funct
'/>"/>

Contact: ESC Press Office
press@escardio.org
44-773-005-7146
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Many Still Tanning, Despite Dangers, Survey Finds
2. Despite less play, childrens use of imagination increases over 2 decades
3. Despite hardships, black men in urban communities are resilient, MU researcher says
4. Despite clear benefits, heart failure clinics are rarely utilized
5. Seniors Creativity Can Thrive Despite Dementia
6. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
7. Ethnic disparities in breast cancer survival remain despite socioeconomic similarities
8. Pneumonia remains the leading killer of children despite decline in global child deaths
9. Despite FDA Warning, Sports Supplements Still Available Online: Study
10. Despite hype, costly prostate cancer treatment offers little relief from side effects
11. Many U.S. Teens at Risk for Suicide Despite Treatment: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 Marketing ... #1 ranked international water, sanitation and hygiene nonprofit by ... communities across the world and it brings our agency ... CEO of Marketing Maven. “The ongoing relationship between ... available for people to learn about and support the ...
(Date:5/6/2015)... Wolters Kluwer , a leading ... announced today that in a survey of nearly 16,000 ... the clinical decision support resource improves the quality of ... UpToDate users in more than 170 countries worldwide viewed ... average. In Germany alone, 95% of all university hospitals ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TU-Automotive has ... car and autonomous vehicles make it to the headlines ... including Ford, Nissan, GM, Volvo and Hyundai ready to ... – this is the only way for press to ... , Charlotte Wright, marketing director, TU-Automotive said “This year ...
(Date:5/6/2015)... Norcross, GA (PRWEB) May 06, 2015 ... has chosen Hexagon Geospatial technology to manage and distribute ... , Australia is one of the driest continents on ... supply through times of drought and erratic seasonal rainfalls ... water supply solutions. , Water NSW manages raw water ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc . ... to help small-to-medium businesses secure their sensitive data more ... teaming up to transition SafeMonk customers to Sookasa’s feature-rich ... welcome SafeMonk users to the Sookasa family, and it’s ... the global powerhouse SafeNet (now Gemalto IDSS), are giving ...
Breaking Medicine News(10 mins):Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3
... published a study in the August issue of their ... diet is more effective in treating// type-2 diabetes than ... better than single agent therapy with oral diabetes drugs. ... control, cholesterol reduction, weight control, and kidney function was ...
... vital information to the surgeon on the extent of ... to complete the procedure// has been developed by VIACORTIS. ... actively beating heart, while having a real-time indication of ... surgical interventions on beating heart safer. ...
... Children's Medical Center in Salt Lake City have successfully ... a 16-hour surgery. ,Doctors pronounced the separation ... the abdomen successful, but cautioned that they would have ... extensive reconstructive surgery. The survival rate of the ...
... claims that Maoris carry a "warrior" gene which make ... acts, terming such claims// as dangerous and inflammatory. ... at Environmental Science and Research, Dr Rod Lea and ... monoamine oxidase, often referred to as the warrior gene, ...
... government’s plan that was announced on Tuesday, to involve thousands ... which has spread deep// into the countryside has been welcomed ... ,It was reported that the focus on the rural areas ... HIV positive people live in the country's villages. Reports now ...
... Pennsylvania School of Medicine have collaborated in an effort ... the abdominal cavity to perform the function of exchanging ... may help lungs recover better in lung failure and ... in the August issue of Chest, the journal of ...
Cached Medicine News:Health News:Triple-Monitoring System To Monitor Heart Viability During Surgery 2Health News:Successful Separation Of Conjoined Twins 2Health News:Warrior Gene Claims Slammed by Maori 2Health News:Warrior Gene Claims Slammed by Maori 3Health News:India Launches A Massive Campaign Against HIV/AIDS In Rural Areas 2Health News:Abdomen Can Help In Gas Exchange In Lung Failure 2Health News:Abdomen Can Help In Gas Exchange In Lung Failure 3
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is pleased to ... to resolve lawsuits involving individuals who were allegedly harmed ... by Takeda Pharmaceuticals - has been associated with thousands ... firm,s attorneys were instrumental in the coordination and negotiation ... - Founding Partner of Fibich, Leebron, Copeland, Briggs & ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ( ... based Ablation Devices - Global Strategic Business Report" report ... analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates ... Also, a seven-year historic analysis is provided for these markets. ...
(Date:5/6/2015)... 6, 2015 3D Communications ... process for helping pharmaceutical companies communicate the value ... The newly expanded 3D Market ... beyond helping companies develop and deliver their "Value ... and engage critical stakeholders earlier in the "innovation-to-market" ...
Breaking Medicine Technology:Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 33D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3
... at 24 Months, SAN DIEGO, Dec. 12 ... a Phase 1 clinical trial of CERE-120 in ... therapy to,deliver the neural growth factor neurturin to ... brains of Parkinson,s disease,patients. Long-term follow up assessments ...
... WASHINGTON, Dec. 12 According to data,released by the ... be more likely to consider taking an,over-the-counter (OTC) statin ... use an OTC had decreased since 2004. The findings ... of a joint meeting of two Food and,Drug Administration ...
Cached Medicine Technology:Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4Survey Finds At-Risk Consumers Interested in OTC Statin 2Survey Finds At-Risk Consumers Interested in OTC Statin 3Survey Finds At-Risk Consumers Interested in OTC Statin 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: